Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's session, 18 companies made new 52-week lows.
Wells Fargo Downgrades NeuroPace to Equal-Weight, Announces $11 Price Target
Wells Fargo analyst Lawrence Biegelsen downgrades NeuroPace (NASDAQ:NPCE) from Overweight to Equal-Weight and announces $11 price target.
59 Biggest Movers From Yesterday
Gainers
SeaChange International, Inc. (NASDAQ: SEAC) jumped 128.8% to $1.72 following Bloomberg report suggesting that social video app Triller is in merger talks with Seachange.
NeuroPace Reports Receives Investigational Device Exemption Approval To Initiate NAUTILIUS Pivotal Study For Its RNS System
IDE study will be first to evaluate the effectiveness of brain-responsive neuromodulation to treat primary generalized epilepsy in patients aged 12 and older
MOUNTAIN VIEW, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) --
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell
• LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
Watching NeuroPace Shares Following Mention Of Co. In Recent STAT News Article ‘In research first, jolts from a customized brain implant provided immediate relief to a severely depressed patient, scientists say’
https://www.statnews.com/2021/10/04/deep-brain-stimulation-depression-relief-research/